Citadel Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-605,300
Closed -$60.1M 10284
2019
Q3
$60.1M Sell
605,300
-48,400
-7% -$4.6M 0.03% 654
2019
Q2
$60.4M Sell
653,700
-340,400
-34% -$32.3M 0.03% 620
2019
Q1
$93.8M Sell
994,100
-504,300
-34% -$44.1M 0.05% 388
2018
Q4
$96M Sell
1,498,400
-210,400
-12% -$15.5M 0.05% 334
2018
Q3
$153M Sell
1,708,800
-527,800
-24% -$46.6M 0.07% 260
2018
Q2
$178M Buy
2,236,600
+32,900
+1% +$2.73M 0.09% 185
2018
Q1
$197M Buy
2,203,700
+1,653,700
+301% +$159M 0.11% 131
2017
Q4
$57.4M Sell
550,000
-360,200
-40% -$40.6M 0.03% 550
2017
Q3
$133M Sell
910,200
-73,100
-7% -$9.96M 0.1% 169
2017
Q2
$128M Buy
983,300
+155,500
+19% +$19.1M 0.11% 165
2017
Q1
$103M Buy
827,800
+201,800
+32% +$24.1M 0.09% 192
2016
Q4
$72.5M Sell
626,000
-10,000
-2% -$1.11M 0.07% 251
2016
Q3
$66.5M Buy
636,000
+122,300
+24% +$13.2M 0.07% 278
2016
Q2
$50.7M Buy
513,700
+11,500
+2% +$1.19M 0.06% 334
2016
Q1
$50.3M Sell
502,200
-214,200
-30% -$22.1M 0.06% 297
2015
Q4
$85.8M Buy
716,400
+34,500
+5% +$3.99M 0.09% 223
2015
Q3
$73.8M Buy
681,900
+7,400
+1% +$918K 0.07% 282
2015
Q2
$78.1M Sell
674,500
-89,100
-12% -$10.2M 0.07% 310
2015
Q1
$88M Sell
763,600
-216,500
-22% -$25.9M 0.08% 263
2014
Q4
$110M Buy
980,100
+167,800
+21% +$17.7M 0.11% 178
2014
Q3
$77M Buy
812,300
+144,500
+22% +$13M 0.08% 249
2014
Q2
$57.4M Buy
667,800
+46,600
+8% +$3.54M 0.07% 323
2014
Q1
$43.4M Sell
621,200
-179,800
-22% -$14.2M 0.05% 452
2013
Q4
$67.7M Sell
801,000
-224,000
-22% -$17.7M 0.09% 250
2013
Q3
$78.9M Buy
1,025,000
+182,400
+22% +$12.8M 0.12% 174
2013
Q2
$49.3M Buy
+842,600
New +$50.7M 0.08% 266

Other funds holding CELG

Citadel Advisors's CELG Position: Q4 2019 in Review

Citadel Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,854,309 shares — an estimated $681M sold.

Citadel Advisors first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $681M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Citadel Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Citadel Advisors sold 6,854,309 Celgene Corp shares in Q4 2019, an estimated $681M.
  • Citadel Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Citadel Advisors's Celgene Corp position peaked at $681M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.